Male Breast Cancer Completed Phase 2 Trials for Vinorelbine (DB00361)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00017394Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast CancerTreatment